198 related articles for article (PubMed ID: 28709911)
1. Increased drug load and polymer compatibility of bilayered orodispersible films.
Carolina Visser J; Weggemans OAF; Boosman RJ; Loos KU; Frijlink HW; Woerdenbag HJ
Eur J Pharm Sci; 2017 Sep; 107():183-190. PubMed ID: 28709911
[TBL] [Abstract][Full Text] [Related]
2. Orodispersible films in individualized pharmacotherapy: The development of a formulation for pharmacy preparations.
Visser JC; Woerdenbag HJ; Crediet S; Gerrits E; Lesschen MA; Hinrichs WLJ; Breitkreutz J; Frijlink HW
Int J Pharm; 2015 Jan; 478(1):155-163. PubMed ID: 25448577
[TBL] [Abstract][Full Text] [Related]
3. Continuous manufacturing and analytical characterization of fixed-dose, multilayer orodispersible films.
Thabet Y; Lunter D; Breitkreutz J
Eur J Pharm Sci; 2018 May; 117():236-244. PubMed ID: 29499348
[TBL] [Abstract][Full Text] [Related]
4. Development, In Vitro and In Vivo Evaluation of Racecadotril Orodispersible Films for Pediatric Use.
Wang B; Yang L; Wang B; Luo C; Wang Y; Wang H; Chen F; Xiang X
AAPS PharmSciTech; 2021 Jan; 22(1):15. PubMed ID: 33389269
[TBL] [Abstract][Full Text] [Related]
5. Prolonged release from orodispersible films by incorporation of diclofenac-loaded micropellets.
Speer I; Lenhart V; Preis M; Breitkreutz J
Int J Pharm; 2019 Jan; 554():149-160. PubMed ID: 30414477
[TBL] [Abstract][Full Text] [Related]
6. Comparative study on disintegration methods for oral film preparations.
Speer I; Steiner D; Thabet Y; Breitkreutz J; Kwade A
Eur J Pharm Biopharm; 2018 Nov; 132():50-61. PubMed ID: 30201569
[TBL] [Abstract][Full Text] [Related]
7. Prolonged drug release properties for orodispersible films by combining hot-melt extrusion and solvent casting methods.
Speer I; Preis M; Breitkreutz J
Eur J Pharm Biopharm; 2018 Aug; 129():66-73. PubMed ID: 29792911
[TBL] [Abstract][Full Text] [Related]
8. FORMULATION, EVALUATION AND IN VITRO DISSOLUTION PERFORMANCE OF ENALAPRIL MALEATE SUSTAINED RELEASE MATRICES: EFFECT OF POLYMER COMPOSITION AND VISCOSITY GRADE.
Shah A; Khan GM; Ullah H; Khan KA; Ullah K; Khan SA
Acta Pol Pharm; 2016 Jul; 73(4):1037-1043. PubMed ID: 29648730
[TBL] [Abstract][Full Text] [Related]
9. Development of orodispersible polymer films containing poorly water soluble active pharmaceutical ingredients with focus on different drug loadings and storage stability.
Woertz C; Kleinebudde P
Int J Pharm; 2015 Sep; 493(1-2):134-45. PubMed ID: 26216415
[TBL] [Abstract][Full Text] [Related]
10. Development of orodispersible polymer films with focus on the solid state characterization of crystalline loperamide.
Woertz C; Kleinebudde P
Eur J Pharm Biopharm; 2015 Aug; 94():52-63. PubMed ID: 25976316
[TBL] [Abstract][Full Text] [Related]
11. Continuous inkjet printing of enalapril maleate onto orodispersible film formulations.
Thabet Y; Lunter D; Breitkreutz J
Int J Pharm; 2018 Jul; 546(1-2):180-187. PubMed ID: 29753906
[TBL] [Abstract][Full Text] [Related]
12. Dual release and molecular mechanism of bilayered aceclofenac tablet using polymer mixture.
Van Nguyen H; Nguyen VH; Lee BJ
Int J Pharm; 2016 Dec; 515(1-2):233-244. PubMed ID: 27744034
[TBL] [Abstract][Full Text] [Related]
13. Effect of type and ratio of solubilising polymer on characteristics of hot-melt extruded orodispersible films.
Low AQ; Parmentier J; Khong YM; Chai CC; Tun TY; Berania JE; Liu X; Gokhale R; Chan SY
Int J Pharm; 2013 Oct; 455(1-2):138-47. PubMed ID: 23916824
[TBL] [Abstract][Full Text] [Related]
14. A novel unit-dose approach for the pharmaceutical compounding of an orodispersible film.
Foo WC; Khong YM; Gokhale R; Chan SY
Int J Pharm; 2018 Mar; 539(1-2):165-174. PubMed ID: 29414124
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of an orodispersible film containing drug nanoparticles.
Shen BD; Shen CY; Yuan XD; Bai JX; Lv QY; Xu H; Dai L; Yu C; Han J; Yuan HL
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1348-56. PubMed ID: 24103635
[TBL] [Abstract][Full Text] [Related]
16. Model-based description of disintegration time and dissolution rate of nanoparticle-loaded orodispersible films.
Steiner D; Finke JH; Kwade A
Eur J Pharm Sci; 2019 Apr; 132():18-26. PubMed ID: 30794870
[TBL] [Abstract][Full Text] [Related]
17. Quality by design approach for optimizing the formulation and physical properties of extemporaneously prepared orodispersible films.
Visser JC; Dohmen WM; Hinrichs WL; Breitkreutz J; Frijlink HW; Woerdenbag HJ
Int J Pharm; 2015 May; 485(1-2):70-6. PubMed ID: 25746737
[TBL] [Abstract][Full Text] [Related]
18. Orodispersible films: Product transfer from lab-scale to continuous manufacturing.
Thabet Y; Breitkreutz J
Int J Pharm; 2018 Jan; 535(1-2):285-292. PubMed ID: 29146537
[TBL] [Abstract][Full Text] [Related]
19. Design, Preparation and Evaluation of HPMC-Based PAA or SA Freeze-Dried Scaffolds for Vaginal Delivery of Fluconazole.
Gafitanu CA; Filip D; Cernatescu C; Rusu D; Tuchilus CG; Macocinschi D; Zaltariov MF
Pharm Res; 2017 Oct; 34(10):2185-2196. PubMed ID: 28707165
[TBL] [Abstract][Full Text] [Related]
20. Hydroxypropyl Methylcellulose Orodispersible Film Containing Desloratadine for Geriatric Use: Formulation and Evaluation.
Al-Oran AYF; Yenilmez E
Antiinflamm Antiallergy Agents Med Chem; 2023; 22(2):79-91. PubMed ID: 37904551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
